continue to site
"Trust in the Lord with all thine heart; and lean not unto thine own understanding. In all thy ways acknowledge him, and he shall direct thy paths."
- Proverbs 3:5-6
August 2020
Issue
health living travel food shop to do jobs
home health living travel food shop to do jobs trending magazine Contact Us Advertise
UArizona, State of Arizona Expand Eligibility for COVID-19 Antibody Testing in Concert with $7.7M Study to Better Understand Immunity
By Lisa Padilla - Thursday Jul 23, 2020
Following a significant increase in the number of Arizonans who have been exposed to COVID-19, the University of Arizona and state of Arizona are expanding their free COVID-19 antibody testing program for 250,000 people across the state to include 15 new categories of essential workers considered at high risk for exposure. The antibody test, developed by researchers at UArizona Health Sciences, determines who has been exposed to and developed an immune response against COVID-19.

The following essential workers, in addition to workers in eight other employment categories, are now eligible for antibody testing under the program:

Educators
Child care workers
Agriculture, grocery and food service workers
Hospitality employees
Solid waste collection workers
Transportation services workers
Members of the National Guard

Health care workers and first responders continue to have access to the testing. More information and registration for the test is available at http://www.covid19antibodytesting.arizona.edu.

"Our antibody test is exceedingly accurate in determining who has developed an immune response against the COVID-19 virus. Combined with other tools such as diagnostic testing and contact tracing, it can help us better understand exposure, spread and levels of protection in our communities," said Deepta Bhattacharya, one of the developers of the antibody test and an associate professor in the UArizona College of Medicine – Tucson's Department of Immunobiology.

Significant Immunity Study Launching

In conjunction with the expanded testing eligibility, the university also is launching a $7.7 million yearlong study funded by the U.S. Centers for Disease Control and Prevention to identify patterns of COVID-19 immunity over time in previously and newly infected individuals. Dr. Jeff Burgess, associate dean for research and a professor at the Mel and Enid Zuckerman College of Public Health, is serving as principal investigator for the study, named the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance, or AZ HEROES, Study.

"The research questions we intend to answer will help us understand how long immunity to COVID-19 persists, and if secondary exposures to the virus are handled differently by the body than the initial exposure," Burgess said.

The research team will seek to enroll 4,000 health care workers, first responders and other frontline workers as participants in the study, who will participate in weekly COVID-19 surveillance and quarterly antibody testing. For questions about the AZ HEROES Study, call the study team at 520-848-4026, or email [email protected].

Karen Lutrick of the College of Medicine – Tucson; Kate Ellingson and Dr. Joe Gerald of the College of Public Health; and Bonnie LaFleur, a research professor of biostatistics at the UArizona BIO5 Institute, are co-investigators for the study. Dr. Janko Nikolich-Zugich, one of the developers of the antibody test, head of the Department of Immunobiology and co-director of the Center on Aging, will oversee the biological analyses for the study.

Differences in COVID-19 Testing

There are three types of tests that are being deployed during the pandemic – two that use nasal swabs to diagnose whether an individual is currently infected with the COVID-19 virus, and one that uses a blood draw to determine whether an individual has developed antibodies and an immune response against the virus. An antibody test is not used to diagnose an active infection.

The antibody test developed at UArizona Health Sciences is one of the most accurate in the country. The testing lab uses two different viral proteins, both of which must return antibody signals for a sample to be called positive. Tests have been further validated in the lab to confirm the presence of virus-neutralizing antibodies, the best available measure of immunological protection.

By UArizona